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Abstract
Secondary plant metabolites, such as the
flavonoids epigallocatechin gallate (EGCG) and
proanthocyanidins (PAC) have been linked to
Studies
numerous health promoting activities.
addressing flavonoid antiviral activity, however,
have been directed towards testing infectivity and
investigating inhibition of metabolic processes
associated with viral growth in the host cell. Few
studies have addressed the direct loss of viral
activity by plant metabolites in a cell-free system. In
the current study, the extent of antiviral
activity by a structurally diverse group of
flavonoids present in cranberry juice and grape
juice (proanthocyanidins), citrus fruits (hesperidin,
naringin, and diosmin), and green tea (catechins)
was investigated using a quantitative antigen
capture enzyme linked immunoassay (ELISA) in a
cell-free system of simian rotavirus strain SA-11
(RTV). The RTV, representative of an enteric
virus, was placed in MA104 cell cultures and
tested by endpoint dilution. PACs at 100 and 200
g/mL caused a direct loss of virus activity at 56%
and 92%, respectively, as compared with the
control.
Use of EGCG at 80 and 160 g/mL
resulted in a loss of RTV infectivity of 45 and
>98%. Individual tests with the PAC components
10

catechin and epicatechin (EC) required increased
concentrations (ca. 5000 to 10,000 g/mL) to cause
an RTV antigen loss approaching 50%. The combined use of catechin and EC had no significant
synergistic effect on the loss of RTV capsid
antigen. Tests with the flavanones (hesperidin and
naringin) and the semisynthetic isoflavone (diosmin)
displayed antiviral activity at a concentration of
1200 g/mL. PAC extract at 200 g/L inhibited
RTV-induced hemagglutination, suggesting an
inhibitory effect on the binding of RTV antigenic
determinants to RBC receptors. Gold-labeled immunoelectron microscopy showed RTV particles
entrapped or sequestered with PAC aggregates.
These findings suggest two things: first, recognition that the potential antiviral efficacy of flavonoids is related to structural differences between
groups and within subgroups, and second, antiviral (anti-RTV) activity occurs at the virusflavonoid interface in the absence of the viral host
cell.
INTRODUCTION
Numerous health promoting activities have
been associated with the consumption of selected
plant juices, such as cranberry and grape, and with

Lipson,: Flavonoid-associated direct loss of rotavirus antigen/antigen act

green tea (Howell, 2009; Cooper, 2012). Current
evidence suggests that flavonoid (phenolic) components, especially epigallocatechin gallate and the
proanthocyanidins, observed in a number of plant
species may have a significant impact on human
health (Aron and Kennedy, 2008; Bose et al., 2008;
Higdon and Frei, 2003; Xiao et al., 2011).
Flavonoid-associated antimicrobial effects have been
the subject of a number of reports (Calzada et al.,
2001; Gescher et al., 2011; Guay, 2009; 2010; Kim
et al., 2010; Lipson et al., 2010; Lu et al.,2004; Mim
and Hart, 2003; Mukhtar et al., 2008; Mukoyama et
al., 1991; Nagi et al., 1992; 1995; Nair et al., 2002;
Roh and Jo, 2011; Song et al., 2005; Suzutani et al.,
2003; Thapa et al., 2012; Zakay-Rones, et al., 2004),
proposing consumption of comestible plants and their
products act on bacteria (E. coli in urinary tract
infections), viruses (herpes simplex virus, human
immune deficiency virus, respiratory syncytial virus,
and hepatitis C virus among others, plus the parasites
(Entamoeba histolytica and Giardia lamblia).
More specifically, the antiviral activity of
flavonoids has been ascribed to several mechanisms,
including blockage of viral antigenic determinants or
cellular receptors, loss of viral/cellular enzyme
integrity/function, inhibition of particle biosynthesis,
and/or particle egress.
Furthermore, antiviral and
antimicrobial activity have been associated with specific flavonoid subclass groups, the catechins and
proanthocyanidins of grapes, berries, and tea, the
flavanones naringenin and hesperetin of citrus fruits,
the flavonols kaempferol, quercetin in onions, kale, and
blueberries. In addition, differences in “R” group
substituents in the phenylbenzopyran A, B, or C rings
of some of these molecules could affect antiviral and
antimicrobial activity (Cushnie and Lamb, 2011;
Lipson et al., 2012; Bae et al., 2000; Foo et al., 2000;
Gharras, 2009; Goldwasser et al., 2011; Savi et al.,
2010; Steinmann et al., 2013; Thapa et al.,2012; Tsai
et al., 2011; Williamson and McCormick, 2006).
Details on flavonoid structure, biochemistry, and
effects on plant physiology have been summarized by
Buer et al., (2010) and Haslam (1998).
Although significant, studies on flavonoid
antiviral and antimicrobial activity at the cellular
level essentially overlook interactions at the plant

metabolite-virus interface.
Except for the recent
reports by Lipson and co-workers using proanthocyanidins and selected plant juices (Lipson et al.,
2011; Lipson et al, 2012), virtually no investigators
have addressed the direct antiviral activity by flavonoid
subclasses in a cell free system. Moreover, no studies
have addressed the effects of flavonoids on enteric
virus mediated hemagglutination – an assay that could
help in understanding the mechanisms in antiviral
activity of flavonoid groups.
This study investigated the potential of direct
antiviral activity of flavonoid subclasses as antiviral
moieties in a cell-free system. The simian rotavirus
SA-11 (RTV) was used throughout this study as a
model enteric virus system.
MATERIALS AND METHODS
Secondary plant metabolites. The secondary
plant metabolites used in study included flavonoids (-) epicatechin), -(-) epicatechin gallate, -(-) epigallocatechin, and (-)- catechin (catechin), were purchased
from Sigma-Aldrich (St. Louis, MO).
Epigallocatechin gallate was purchased from Cayman Chemical
Co. (Chicago, IL).
Cranberry and grape
proanthocyanidin extracts were kindly supplied by
Dr. A. B. Howell (Marucci Center for Blueberry
Cranberry Research, Rutgers University, Chatsworth,
NJ; Foo et al., 2000; Howell et al., 2005). HI PAC
4.0, which is readily soluble in water-base diluents,
was supplied by Decus Botanical Synergies, Carver,
MA. Hesperidin, naringin, diosmin, and dimethylsulfoxide (DMSO) were purchased from SigmaAldrich (St. Louis, MO).
For the experimental trials, the PACs (1000 g
were suspended in two mL sterile distilled H2O and
homogenized on ice for 10 min at high speed in an
OMNI TH homogenizer (OMNI International, Kennesaw,
GA). The flavonones hesperetin, naringin, and diosmin
were solubilized in absolute methanol and >99%
dimethylsulfoxide (DMSO), followed by dilution of
the preparation to yield concentrations of 2.6% and
40% methanol and DMSO containing a flavanone
concentration of 1200 g.
Virus, cell culture, and enzyme immunoassay.
Infectivity titration measurements were used to determine
the number of infectious RTV particles (simian rotavirus
11
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strain SA-11 ATCC VR-1565) (Manassas, VA) added to
our experimental systems. Host cells consisted of African
green monkey kidney epithelial (MA-104) cells, clone
Chlorocebus aethiops grown with titrations in 96-well, flat
bottom microtiter plates.
Growth media (GM) consisted of Eagle’s
minimal essential medium supplemented with 10%
fetal bovine serum (FBS), 100 µg/mL of streptomycin, 100 units of penicillin, 1% L-glutamine, and
1% amphotericin B. The maintenance medium (MM)
was the same as GM except that 2% FBS was added
to the medium supplement. Prior to virus inoculation, the GM was aspirated, and each well was replaced
with MM. Infectivity titers were determined by endpoint dilution and expressed as a tissue cul- ture
infective dose (TCID50/mL) (Reed and Muench,
1938).
Direct loss of viral antigen by flavonoids in cellfree suspension was determined using a viral capsid
protein 6 (VP6) quantitative antigen capture in an
RTV enzyme-linked immunosorbent assay (ELISA)
(PremierTM Rotaclone® Enzyme Immunoassay Assay;
Cat. No. 696004; Meridian Bioscience, Inc., Cincinnati,
OH). The RTV antigen capture ELISA technology
was chosen due to recognition of the quantitative and
qualitative determination of virus infectivity (antigen)
both in the clinical and research settings (Dornai et
al., 1993; Fang et al., 2009; Lipson et al., 2011;
Knowlton et al., 1991; Raj et al., 2007; Stals et al.,
1984; Tran et al., 2010).
Readings were quantitatively determined using a Genesys 20 Spectrophotomer (ThermoFisher, Inc., Waltham., MA) at an
absorbance of 450 nm as per instructions of the
manufacturer specifications.
All experiments and
ELISA titrations were done in triplicate.
Synergistic effects of catechin and epicatechin
on rotavirus activity. To determine possible synergistic activity, the effect of a catechin and EC mixture
(50% each) at 313 and 2500 µg/mL was compared with
each individual flavanol at 313, 625, 1250, and
2500 g/mL.
The mixture of flavanols and each
individual phytochemical were added to separate, but
equal volumes of RTV and incubated in cell-free
suspension for 30 min at room temperature (23oC).
After the incubation period, viral activity was
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determined by the quantitative [capsid] antigen
detection ELISA. Inoculum stock titer was 9.2 x 104
TCID50/mL. The percent activity was determined by
comparison with a control in which no catechin nor EC
were added.
Microhemagglutination-inhibition (HAI). The
inhibition of microhemagglutionation, was tested using
a modification of the procedures of Swenson et al. (1992).
A 7% guinea pig red blood cell concentra- tion,
prepared daily was diluted (1 part blood: 67 parts
buffer) with a phosphate-buffered saline solu- tion
containing no Ca2+ or Mg2+ (PBS) for each experiment.
An equal volume of PBS containing 200
g/mL of the PAC was subsequently mixed with the
PBS containing the blood cells for 30 min incubation at
room temperature (23oC). At the end of the incubation
period, 10 µL of the working strength RBC-PAC
preparation was added to clean glass
slides to which equal volumes of RTV at the tissue
culture infective dose were added. Suspensions were
mixed with a wood applicator and incubated at room
temperature (23oC) for an additional 30 min.
In an effort to separate the effect of the PAC
preparation on the virus and not the RBCs, the RTV
was treated first followed by the immediate addition
of untreated guinea pig RBCs. Careful attention was
placed on the physical handling of control slides,
which, except for the PAC being replaced with PBS,
were identical to experimental slides. The negative
control consisted of RBCs which were treated with
PBS, alone. Additional HAI testing was done using
herperidin, naringin, and diosmin. These flavonoids
were dissolved in methanol or DMSO, diluted in 1X
PBS to achieve a final concentration of 1200 µg/mL
at 1.3 and 20%, respectively.
Experimental and
control preparations were observed by light
microscopy (100X) and photographed.
Interaction of proanthocyandins and rotavirus.
To visualize any interaction of cranberry proanthrocyandins (c-PACs) with rotavirus, transmission electron
microscopy (TEM) was used. Immuno-gold-labeled
rotaviruses in a cell free system were treated with
high molecular weight C-PACs. The primary antibody, which consisted of a mouse monoclonal (3C10)
specific to the viral antigen VP6 (Abcam,
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Cambridge, MA), was diluted 1 part to 20 parts in
PBS. A volume of this antibody mixture was added
to an equal volume of the rotavirus at a concentration
of 9.2 X 105 TCID50/mL. The mixture was incubated
at 37oC for 30 min.
The secondary antibody consisted of a 6 nm
gold-labeled goat-anti-mouse IgG (H+L) conjugate
(Electron Microscopy Sciences, Hatfield, PA), diluted
1:10 in PBS. The diluted secondary antibody was
added to an equal volume of the 3C10-rotavirus
complex and incubated for an additional 30 min at
37oC. The positive control consisted of gold-labeled
virus only, and the negative control consisted of CPACs only. Rotavirus alone or 3C10-treated rotavirus in the absence of the secondary antibody,
showed no artifacts. The gold-labeled immunoelectron microscopy was done using a Hatachi transmission electron microscope.
Cytotoxicity tests. Testing for cytotoxicity was
done using a Toxilight® Non-Destructive Cytotoxicity
Bioassay kit (Cat. No. LT37-619; Lonza, Rockville,
MD). MA-104 cells were grown in a monolayer on
culture flat bottom, 96-well, polypropylene cluster
plates as per specifications of the manufacturer.
Cellular membrane damage was quantified through
the release of adenylate kinase (AK) driving (in part)
the lucinferin/luciferase assay to produce an ATP
“spark.”
Catechin and EC at 5000 and 10,000 g/mL in
1.3 and 2.6% methanol were added to the prepared
MA-104 culture monolayers and incubated for 5, 30,
and 60 min periods at room temperature (23 oC).
Cytotoxicity was evaluated after each incubation
period. The positive control consisted of an ammonium
chloride-based lysing reagent (Cat. No. LT07-517;
Lonza, Rockville, MD) in the absence of methanol and
in 1.3 or 2.6% methanol. The negative control
consisted of phosphate-buffered saline
containing either 1.3 or 2.6% methanol. Identical
testing was done using 100 µg/mL cranberry-PACs
(C-PACs), grape-PACs (G-PACs), and 160 g/mL
EGCG. Results were reported as relative light units
(RLUs) employing a Modulus luminometer (Model
No. 9200-003; Turner Biosystems/Promega Corp.,
Sunnyvale, CA).

RESULTS
Effect of flavonoids on the loss of rotavirus
activity. EGCG and cranberry PACs (C-PACs) were
effective anti-RTV plant secondary metabolites, with
loss of RTV antigen activity (as determined by VP6
function) at 160 and 200 µg/mL to >98 and 90% of
control, respectfully. Anti-RTV activity by selected
catechin isomers, epicatechin (EC), epigallocatechin
(EGC), and epicatechin gallate (ECG), was markedly
less effective, requiring concentrations >2000 µg/mL
to reduce viral activity reductions to ca. 38, 50, and
78%, respectively (Table 1 & Figure 1).
Table 1. Loss of rotavirus antigen structural integrity.
Virus
Concentration
Plant
Significance
antigen
metabolites
(P-value)3
(g/mL) 1
2
(% loss)
Proanthocyandin
100
66
0.002
Proanthocyandin
200
92
<0.001
Naringin
1200
0
Hesperidin
0
1200
Diosmin
1200
0
1

Metabolites were solubilized in methanol to working concentration
of 1.3%.
2
Loss of antigen was determined by enzyme immunoassay.
3
Student’s t-test, p<0.05, n =3; value <0.95 were considered significant.

Figure 1. Effect of epigallocatechin gallate, epicatechin gallate,
and epigallocatechin on rotavirus antigen loss.
Note: Experimental trials were done in a cell free suspension for 30
minutes at room temperature; loss of RTV activity was measured by
the reduction of VP6 antigen levels as determined by an antigencapture ELISA. EGCG = epigallocatechin gallate, ECG = epicatechin
gallate, EGC = epigallocatechin.
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The flavanones naringin, hesperidin, and the
isoflavone diosmin had no direct effect on the loss of
viral antigen activity in our experimental system at
concentrations equal to or slightly greater than 1200
µg/mL. In the test system, higher flavanone concentrations (>2,400 µg/mL) precipitated from the methanol carrier upon mixing with maintenance medium
or PBS. Markedly increased concentrations of 23 and
25 x 103 µg/mL of “HI PAC 4.0” were required to
affect a loss of RTV activity that approximated 50 to
90% of the control, respectively (Figure 2). The high
solubility of “HI PAC 4.0” (Anonymous, 2010)
permitted use of the inordinately high concentrations
of this commercially available product in our experimental cell- free assay system.

Figure 2. The effect of “HI PAC 4.0” on rotavirus antigen loss.
Note: RTV suspensions were added to equal volumes of “HI PAC
4.0” powder dissolved in phosphate buffered saline with rotavirus
activity measured after 30 minutes. Rotavirus concentration was 9.2 x
104 TCID 50/mL. The results are reported as the mean ± SEM of three
replicates

Synergistic effects of epicatechin (EC) and
catechin on rotavirus activity.
The flavanol
molecular groups, EC and catechin (at a final
concentration of 313 g/mL) added alone or in combination to RTV in a cell-free suspension had no
significant effect on the loss of RTV activity. Similarly,
neither EC nor catechin at the same concentration¸
showed any antiviral activity. RTV activity was
significantly reduced to 71% of control when treated
with EC-catechin mixture at 2500
g/mL, but did not approach that of catechin (625,
1250, or 2500 µg/mL) (Figure 3). The i nordinately.
14

high catechin concentrations of 625, 1250, and 2500
µg/mL, although affecting RTV antigen reductions
(loss of viral activity) to 65, 73, and 78% respec- tively,
failed to approximate that of PAC or EGCG associated
anti-RTV activity (92 to >98%, respective- ly) at
markedly reduced levels.

Figure 3. Effects of epicatechin and catechin on the loss of rotavirus
activity in cell-free suspension.
Note: Concentrations of epicatechin, catechin, and the combination
were incubated with equal volumes of rotavirus at room temperature
for 30 minutes. Rotavirus concentration was 9.2 x 104 TCID50/mL and
the activity was quantified using the capsid antigen. The results are
reported as the mean ± SEM of three replicates.

Cytotoxicity testing. Cytotoxicity was not observed
with either the cranberry (C-PAC) or the grape (GPAC) tested concentrations (100 µg/mL) nor by
that of the catechin isomer EGCG at 160
µg/mL (Figure 4). C-PAC at 200 µg/mL produced no
adverse effect on cellular integrity during cytotoxicity
testing (data not shown). Similarly, EC and catechin,
each tested at concentrations 5,000 and 10,000 µg/mL
and containing 1.3 or 2.6% methanol, had no overt
effect on MA-104 cell membrane integrity as determined by the cytotoxicity bioassay (Figure 5). The
flavonoid and alcohol concentrations used in the
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cytotoxicity testing approximated those used in the
anti-RTV experimental system.

Microhemagglutination-inhibition. A microscopic examination (100X) of the rotavirus and red
blood cells (RBCs) at 30 min, after each were
pretreated with 200 µg/mL
PACs at room
temperature for 30 min, showed the pretreatment with
the proanthocyanidins prevented cellular aggregation
by RTV. Treatment of RTV in suspension by PACs
followed by an immediate inoculation of RBCs,
similarly inhibited cellular (RBC) aggregation.
Herperitin, naringin, or diosmin at1200 µg/mL (in
methanol or DMSO) displayed no microhemagglutination inhibition activity.
Under identical
conditions, but using an RTV-PBS preparation
(positive control), hemagglutination was apparent
(Figure 6). PBS alone had no effect on the RBC
aggregation (not shown).

Figure 4. Cytotoxicity test.
Note: Adenylate kinase released by damaged cellular membranes
resulted in ATP used in the lucinferin-luciferase Toxilight Bioassay.
Measures of cytotoxicity after 60 min at room temperature indicated
the cranberry-PACs, the grape-PACs, and the epigallocatechin gallate
protected cellular membranes. The positive control was NH4Cl lysing
reagent (Lonza, Rockville, MD). The negative control was a buffered
phosphate buffered saline solution. The results are the mean ± SEM
of three replicates.

Figure 5. The effect of methanol on prevention of cytotoxicity
by catechin and epicatechin.
Note: Catechin and epicatechin were added to MA-104 cell culture
monolayers and incubated for 5, 30 (not shown), and 60 minutes at 37
o
C in the presence of 1.3 and 2.5% methanol. The positive controls
were NH4Cl and the negative controls consisted of PBS + the indicated
methanol level. No negative effects on cellular integrity due to methanol were noted. Results are means ± SEM of three replicates.

Figure 6. Microhemagglutination inhibition.
Note: A = inhibition of RBC aggregation following virus or
pretreatment with PACs. B = a positive control consisting of
RTV-PBS preparation showing RBC aggregates. The negative
control, RBC treated with PBS, had no hemagglutination.
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Electron microscopy. Electron microscopy of the
incubated mixture of equal volumes of gold-labeled
RTV (9.2 x 105 TCID50/mL) and PAC preparations
(200 g/mL) showed morphological intact RTV
particles were heterogeneously dispersed throughout
the preparations. Virions, made visible by the gold-

labeling, appeared to be sequestered or embedded
within the PAC particulate fraction (Figure 7).
Earlier attempts to differentiate non-labeled
RTV in association with the flavonoid in question
proved futile, due to the near opaque nature of the
phenolic under transmission electron microscopy.

Figure 7. Entrapment of rotavirus by proanthocyanidin particulates.
Note: A & B = RTV sequestered with PAC particles; C = Positive control consisting of gold-labeled virus in the absence of PACs;
D = Negative control consisting of PACs only. No artifacts similar to the 6 nm gold particles were observed (data not shown). RTV
entrapment and envelopment by both PAC particulate and solubilized fractions occurred in the water column.

DISCUSSION
Among the catechin group of flavonoids tested,
a direct loss of RTV antigen in cell-free suspension
occurred in the of EGCG > ECG > EGC > EC = (-)catechin. The catechin group of plant metabolites
(EGCG, ECG, EGC, EC) are characterized in part, by
the flavan-3-ol backbone skeleton. Importantly, these
molecules become structurally discrete by location and
16

differences in substituent side groups on the rings
designated B and C (Figure 8).
Specifically, the
galloyl moiety bound to the EGCG and ECG at the
benzopyrene-2 position (position C3 of the benzopyrene molecular component), appears to be associated with the increased anti-RTV activity of these
two molecules. The galloyl moiety per se, however,
cannot in itself, be considered with the enhanced anti-
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RTV activity. The markedly enhanced direct antiRTV activity fostered by EGCG, appears to be
supplemented by a trihydroxylation of the aromatic B
ring of the molecule (Cos et al., 2003; Zanchi et al.,
2009).

Figure 8. Major catechins in green tea (Camellia sinensis).
Note: Epigallocatechin gallate (EGCG) is the most abundant in green
tea, but minimal in black tea due to the manufacturing process.

In support of our findings, comparative studies
have ascribed the importance of individual catechin

species, notably EC, EGC, ECG, EGCG, to alterations in viral structural integrity and then in turn
infectivity.
Using several influenza virus strains,
Song, et al. (2005) reported a loss, with one excep- tion,
of viral envelope integrity (neuraminidase), reduced
RNA synthesis, and reduced infectivity following viral
treatment by select catechins in the order
EGCG>ECG>EGC. These findings were ascrib- ed to
galloylation at the 3- hydroxyl of the flavon-3-ol catechin
skeleton and to a lesser extent to the 5’-OH at the
trihydroxylbenzyl -2 position. Additional studies were
done to address the antiviral activity and structural
significance of EGCG (using the herpes simplex virus
type-1, HSV-1) in comparison with
EC
(dihydroxylated), EGC (trihydroxylated), and the dihydroxyl galloylated gallocatechin molecular groups
(Gescher at al., 2011). Comparative testing again
ascribed the significantly enhanced (100-fold) antiviral activity of EGCG to both trihydroxylation and
galloylation of the B and C ring systems, respectively,
of the molecules.
Galloylation and trihydroxylation at the C ring
and B ring, respectfully, have been similarly recognized to explain enhanced EGCG activity against
HSV-2 (Isaacs et al., 2008). Using the hepatitis C
virus (HCV), Roh and Jo (2011) have reported a remarkable inhibition of HCV infectivity as determined
by a reduction of the viral polymerase nonstructural
protein, NS5B (an RNA dependent-RNA polymerase),
following HCV treatment with EGCG. Other flavonoids, including, but, not limited to naringenin,
hesperetin, quercetin, and (-)-catechin, affected virtually no anti-HCV (polymerase) activity. Similarly,
EGCG concentrations at 70 to 100 µM inhibited
expression of immediate-early and other Epstein-Barr
virus (EBV) proteins using an EBV-positive
Burkett’s lymphoma cell line. Differences in flavonoid antiviral activity in relation to other poly- phenolic
structural characteristics, however, was not addressed
(Chang et al., 2003).
Some two decades earlier, antiviral activity by
EGCG of several human RTV and enterovirus strains
not only showed a differential EGCG-mediated
antiviral effect between human RTV strains and
enterovirus groups, but differences in antiviral
activity even between strains within the same
17
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[enterovirus] group (Mukoyama et al., 1991). The
current study complements recognized anti-[animal]
virus activity by EGCG on the cellular level,
demonstrating the ability of this flavonoid to directly
impart an antiviral effect through the loss of RTV
[VP6] antigen detection or by VP6 integrity in the
cell-free assay system. Apparently, EGCG possesses
broad antiviral activity on the cellular level and can
directly compromise RTV capsid antigen function in
the cell-free system.
Our findings indicate the unique chemical
structure of EGCG (the galloylation and the
trihydroxylation at the aromatic B ring) is responsible
for the reduced detection levels of RTV [antigen]
activity in the cell-free detection system. The apparent broad antiviral activity exhibited by green tea
appears due to the abundant amounts of EGCG in the
tea leaves (Henning et al., 2011) and the direct antiviral
effect of EGCG on rotavirus in suspension. This
observation supports the need to further address the
application of this secondary plant metabolite at the
organismic level.
The anti-RTV activity of EGCG in cell-free
suspension prompted a comparison of this catechin
isomer to the well characterized PAC extract from
cranberries (Vaccinium macrocarpon), under identical conditions. Relatively low PAC concentrations
(100 and 200 µg/mL) similar to that of EGCG, affected
a significant reduction of RTV activity, as measured
through the loss or compromising of RTV viral (VP6)
capsid antigen. The mechanism associ- ated with the
direct effect on RTV activity by PACs (in the cell-free
system) is not fully understood. Electron microscopy,
however, indicated the RTV viral capsid antigen was
entrapped and enveloped by both PAC particulate and
solubilized fractions in the water column, respectively
(Lipson et al., 2011). The apparent tenacity of RTV to
PACs suggests an attachment of this flavonoid to
proline residues within the RTV capsid protein (Estes
et al., 1984; Lipson et al., 2011).
Our proposed mechanism of PAC-RTV attachment is supported in part, by earlier PAC-protein system studies, demonstrating a preferential attachment
of these PACs to proline (Charlton et al., 2002;
Hagerman and Butler, 1981 Ricardo-da-Silva et al.,
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1991). Thus, suggesting a blockage of the V6 capsid
proteins necessary for antibody attachment in the
ELISA system, as well as a potential concomitant
blockage of VP4/VP7 capsid [surface] antigenic
determinants needed for viral attachment and subsequent infection of a host cell is not unreasonable.
Direct PAC-associated antiviral activity being dependent on differences of capsid protein/amino acid
composition is in agreement with other studies
(Gescher et al., 2011). A marked affinity for prolinerich protein by EGCG has been described as well
(Pascal, et al. 2007). On the molecular level, a
hydrophobic-mediated stacking of proline side chains
to specific EGCG ring molecules takes place.
The direct treatment of influenza virus by the
related catechin isomer EGCG and theaflavin could
affect viral aggregation/clumping and thus a
reduction in hemagglutination activity and infectivity
in host cell monolayer cultures (Nakayama et al.,
1993). Of course, a joint or complementary effect on
viral loss of infectivity by EGCG and the theaflavin
in suspension on a cellular level is also possible
(Imanishi et al., 2002).
Viral aggregation and
clumping with reduced attachment to the host cell are
known to alter viral activity/infectivity (Bergey, et
al., 1993; Young and Sharp, 1977).
The PAC extract in the current study was a
complex of dimers, oligomers, and polymers,
consisting of catechin, the isomer EC, and other
flavanol units (Gescher et al., 2011; Pascal et al.,
2007). Although similar in structure, catechin and
epicatechin may have completely different stereochemical configurations at the C2 (trans) and C3 (cis)
positions. Indeed, a synergistic or additive effect was
noted by catechin and EC. High concentrations of
catechin (>625 g/mL), however, were significantly
more effective than any catechin/EC complex.
Synergistic activity between flavonoid subclasses at the cellular level (cellular growth, apoptosis
induction, and antiviral activity) have been reported
(Amoros et al., 1992; Horie et al., 2005).
Mechanistically,
flavanol
complex
formation
apparently affects discrete cellular pathways or
events, such as increased caspase activity and
extracellular H2O2 production, associated with
physiological cell death (Horie et al., 2005) and/or
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inhibition of the cell cycle by stopping the G0-G1
phase (Thakur et al., 2012). Although our system
precluded any descriptive analysis at the cellular
level, we propose that the anti-RTV activity among
the flavanols is associated with steroisomerism and/or
other modifications in molecule structure at the
flavanol-virus interface (Niemeyer and Brodbelt,
2007; Gescher et al., 2011). An anti-RTV synergistic
effect with catechin-EC complexes as compared with
catechin alone, was expected, but did not occur. Indeed,
an antagonistic effect between the catechin- EC
complex reduced activity as compared with catechin (≥
625 g/mL).
The evidence indicates that the
combination of catechin and EC under ordinary
chemical means in the cell-free system does not
mimic that of anti-RTV activity seen in naturally
occurring PAC molecule.
Attempts to induce a direct loss of RTV activity
by using the flavanone glycosides hesperidin,
naringin, and the isoflavone diosmin, proved
inefficacious, suggesting that among these tested noncatechins RTV is not susceptible to direct treatment
by these flavonoids. At the cellular level, antiviral
activity has been reported among hesperidin,
naringin, and diosmin (Amoros et al., 1992; Tang et
al., 2012). The possibility also exists that the method
of flavanone preparation is of significant importance,
except for EGCG and, to a lesser extent PACs
(Lipson et al., 2007, 2011). Flavones are generally
immiscible in water-based solvents/diluents, such as
the cell PBS cell culture medium.
The nonpolar nature of most flavonoids, the use
of organic solvents or carrier molecules, such as
DMSO, are necessary to bring these polyphenols into
solution. The absence of a standardized flavonoidalcohol or DMSO protocol and the lack of
information on the alcohol/DMSO threshold levels
for cell types used in cytotoxicity testing, probably
explain
the
contradictory
reports
on
flavanone/isoflavone antiviral activity in such
infections as sindbus, dengue, and the human RTV
Wa strain (Bae et al., 2000; Paredes, et al., 2003;
Zandi et al., 2011).
The potential for virucidal activity also occurs
when commonly used organic solvents are used to
bring flavonoids to the target site. Cytotoxicity

studies by Da Violante et al. (2002), observed no
significant cell damage in culture monolayers of
Caco-2 cells after some 2 h in medium
supplemented with DMSO concentrations <10%
(Da Violante et al., 2002). A DMSO concentration
of 15% produced no visible cytotoxic effects on HeLa
cells after a 96-h incubation period (Malinin and
Perry, 1967). A recent study in which several
Malasyian plant species were tested for anti-dengue
virus infectivity in Vero cells used DMSO at a
working strength of <1% (Tang et al., 2012).
Anecdotal blogs also suggest DMSO concentration in
cell culture systems should not exceed 0.1 to
0.5% (Protocol Online, 2006).
Identifying appropriate concentration of
methanol and DMSO that did not prove virucidal or
cytotoxic while retain a maximum flavonoid
soluble working strength concentration upon
dilution in PBS was relevant to our study. While
methanol levels of 1.3% and 2.6% were not toxic,
the concentration of 1.3% methanol proved
effective in retaining naringin, hesperidin, an diosmin
at 1200 g/mL. While the naringin, hesperidin, and
diosmin were shown to be soluble in DMSO,
dilution of DMSO solubilized flavonoid preparations
in PBS or culture medium concentrations >20%
precipitated almost immedi- ately. To determine a
real antiviral effect by an experimental flavonoid or
other analyte, the carrier molecule must be benign.
DMSO concentrations ≤
20% proved non-toxic and non-virucidal.
Although the current study demonstrated
direct anti-RTV activity at the virus-flavonoid
interface with EGCG and PACs in a cell-free
suspension, the data show the need for an
inordinately high concentration HI PAC 4.0. The
use of high flavonoid concentrations are not
recommended due the potential of cytotoxicity in
the in vivo system.
The inherently discrete physiochemical,
molecular, and structural/functional differences
among viral species, limits any broad behavioral
and associated biotechnical issues for modifying
virus activity, susceptibility to chemical treatments,
and vaccine and/or drug development (Gerba et al.,
1980; Herrmann et all, 1974; Hashiguhchi et al.,
19
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2007; Krug and Aramini, 2009: Wigginton and
Kohn, 2012).
Of course, among the large number of
reported flavonoid-associated antiviral studies,
some controversy could be expected. For example,
the flavone glycoside hesperidin showed antiviral
activity to the human RTV Wa strain, but not to
Sindbis (SV) nor Enterovirus 71 (E71) and had no
inhibitoroy effect on the replication of the unrelated
Dengue virus (Bae et al., 2000; Paredes et al., 2003;
Zandi et al., 2011). Behavorial differences (loss of
activity/infectivity) among viral strains and strains
within the same genus occur among hepatitis C
virus (HCV) chimeric strains in association with the
flavan-3-ol monomer, EGCG, and studies
employing the HCV JFH1-ΔE1E2 construct have
expounded the antiviral effect of EGCG through
blockage of virion RNA replication (Chen et al.,
2011). The same catechin subgroup failed to inhibit
the HCV Luc-Je1 chimeric strain (Ciesek et al.,
2011).
Chen et al. (2012) have ascribed such
differences in anti-HCV activity by EGCG to
genetically modified strains, although differences in
virus detection methodologies were also suggested.
These studies indicate the need to address the effect
of defined flavonoid classes, viral types/strains, and
methodologies utilized in any evaluation of any
plant metabolite for antiviral activity.
Our current research specifically supports the
specificity or at least, the unique, direct association
among flavonoid groups in animal antiviral (antiRTV) activity. The data clearly indicate the antiviral
activity of flavonoid types need to be addressed
individually. The anti-RTV activity of the four
catechin isomers was EGCG >>> ECG > EGC > EC.
The markedly efficacious anti-RTV activity by
EGCG (approaching 100%) may be ascribed to a
trihydroxylation and galloylation at the B and C
rings, respectively, of the core molecule,
respectively.
PACs,
under
identical
experimental
conditions, affected a loss of RTV antigen of more
than one order of magnitude.
In general, no
significant anti-RTV synergistic effect was
recognized through the combination of EC and
catechin PAC core components. In general, the
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envelopment or entrapment of RTV within colloidal
PAC particulates in water, noted in the electron
micrographs, may have inhibited the viral induced
hemagglutination reaction.
Products mandating
inordinately high concentrations to promote an
antiviral effect should not be considered candidates
for additional testing. Possible PAC-associated loss
of viral activity/antigen detection through a
blockage of VP6 and probably outer capsid
antigenic determinants should be considered
candidate epitopes for additional testing. Further
evaluation of flavonoids for antiviral activity must
consider these molecules' unique structures.
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